Publication Name	World Journal of Gastroenterology
Manuscript ID	80054
Country	United Arab Emirates

Received	2022-09-15 10:13
Peer-Review Started	2022-09-15 10:16
First Decision by Editorial Office Director	2022-11-15 08:02
Return for Revision	2022-11-15 08:02
Revised	2023-01-06 15:29
Publication Fee Transferred
Second Decision by Editor	2023-03-03 03:28
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2023-03-07 18:47
Articles in Press	2023-03-07 18:47
Edit the Manuscript by Language Editor	2023-03-13 00:56
Typeset the Manuscript	2023-03-14 01:39
Publish the Manuscript Online	2023-03-17 06:20

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients
Manuscript Source	Invited Manuscript
All Author List	Khansa Ahsan, Munir Ahmad Anwar and Nayla Munawar
ORCID	Author(s) ORCID Number Nayla Munawar http://orcid.org/0000-0001-9448-2845
Funding Agency and Grant Number
Corresponding Author	Nayla Munawar, PhD, Assistant Professor, Chemistry, United Arab Emirates University, College of Science, United Arab Emirates University, Al Ain 15551, United Arab Emirates. nmunawar@uaeu.ac.ae
Key Words	COVID-19; Gut-liver axis; Probiotics; Prebiotics; Cytokines; Gut microbiome
Core Tip	There are several reviews in the literature contributed to the pathophysiology of liver damage during severe acute respiratory syndrome coronavirus 2 infection. However, we highlight the potential role of gut microbiota in managing drug-induced liver damage during and after coronavirus disease 2019 (COVID-19) infection. We shed light on various metabolites produced by gut microorganisms that have a significant role in reducing liver damage in COVID-19 infection with the use of different probiotics and prebiotics.
Publish Date	2023-03-17 06:20
Citation	Ahsan K, Anwar MA, Munawar N. Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients. World J Gastroenterol 2023; 29(11): 1708-1720
URL	https://www.wjgnet.com/1007-9327/full/v29/i11/1708.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i11.1708

Full Article (PDF)	WJG-29-1708.pdf
Full Article (Word)	WJG-29-1708.docx
Manuscript File	80054-Review-FilipodiaCL.docx
Answering Reviewers	80054-Answering reviewers.pdf
Audio Core Tip	80054-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	80054-Conflict-of-interest statement.pdf
Copyright License Agreement	80054-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	80054-Language certificate.pdf
Peer-review Report	80054-Peer-review(s).pdf
Scientific Misconduct Check	80054-Bing-Liu GL-2.png
Scientific Editor Work List	80054-Scientific editor work list.pdf
CrossCheck Report	80054-CrossCheck report.pdf